1.河南中医药大学第一附属医院国家区域中医(肺病)诊疗中心,河南省郑州市金水区人民路19号,450000
2.河南中医药大学第一临床医学院
通信作者:wmh107hn@163.com
收稿:2025-04-28,
修回:2025-09-28,
纸质出版:2026-02-02
移动端阅览
赵娣,王明航,孟圆圆等.基于多模型融合分析的温肺固元脐灸治疗慢性阻塞性肺疾病稳定期疗效影响因素的回顾性分析[J].中医杂志,2026,67(03):291-303.
ZHAO Di,WANG Minghang,MENG Yuanyuan,et al.Influencing Factors of the Effectiveness of Wenfei Guyuan Umbilical Moxibustion (温肺固元脐灸) for Stable Chronic Obstructive Pulmonary Disease Based on Multi-Model Fusion Analysis:a Retrospective Study[J].Journal of Traditional Chinese Medicine,2026,67(03):291-303.
赵娣,王明航,孟圆圆等.基于多模型融合分析的温肺固元脐灸治疗慢性阻塞性肺疾病稳定期疗效影响因素的回顾性分析[J].中医杂志,2026,67(03):291-303. DOI: 10.13288/j.11-2166/r.2026.03.011.
ZHAO Di,WANG Minghang,MENG Yuanyuan,et al.Influencing Factors of the Effectiveness of Wenfei Guyuan Umbilical Moxibustion (温肺固元脐灸) for Stable Chronic Obstructive Pulmonary Disease Based on Multi-Model Fusion Analysis:a Retrospective Study[J].Journal of Traditional Chinese Medicine,2026,67(03):291-303. DOI: 10.13288/j.11-2166/r.2026.03.011.
目的
2
通过多模型融合分析方法,深入探究影响温肺固元脐灸治疗慢性阻塞性肺疾病(COPD)稳定期患者疗效的关键因素,为临床个体化诊疗提供依据。
方法
2
纳入107例接受温肺固元脐灸治疗的COPD稳定期患者,将其治疗13周、随访26周的研究数据进行清洗整理,分别根据治疗阶段和随访阶段患者是否存在急性加重情况分为急性加重组和未急性加重组,运用Lasso回归、弹性网络、随机森林等方法分别对其进行影响因素的初筛,再以任意两种方法筛选出的共同因素,进行Logistic回归分析,筛选出影响温肺固元脐灸治疗稳定期COPD患者疗效的因素。
结果
2
共纳入患者107例。治疗13周时,采用Lasso回归、弹性网络和随机森林方法筛选出任意2种方法共同筛选出的影响因素5个,分别为乏力评分、血红蛋白(HGB)及健康状况调查问卷(SF-36)—生理机能得分、社会功能得分、身体疼痛得分。Logistic回归分析显示,治疗13周时影响温肺固元脐灸治疗COPD疗效的因素有HGB(
OR
=0.973,
P
=0.031)、SF-36—社会功能得分(
OR
=1.833,
P
=0.043)。随访26周时,采用Lasso回归、弹性网络和随机森林方法筛选出任意2种方法共同筛选出的影响因素7个,分别为咯痰评分、喘息评分、乏力评分、SF-36—精力得分、SF-36—精神健康得分、慢阻肺患者报告结局量表修订版(mCOPD-PRO)—环境领域得分、慢阻肺患者疗效满意度问卷修订版(mESQ-COPD)—环境适应能力得分。Logistic回归分析显示,随访26周影响温肺固元脐灸治疗COPD疗效的因素有咯痰评分(
OR
=2.175,
P
=0.042)、SF-36—精神健康得分(
OR
=1.312,
P
=0.012)。
结论
2
HGB、咯痰症状、社会功能和精神健康可能是影响温肺固元脐灸治疗COPD临床疗效的因素。
Objective
2
To explore the key factors influencing the effectiveness of
Wenfei Guyuan
Umbilical Moxibustion (温肺固元
脐灸) in the treatment of patients with stable chronic obstructive pulmonary disease (COPD) through a multi-model fusion analysis, so as to provide a basis for clinical individualized diagnosis and treatment.
Methods
2
A total of 107 patients with stable COPD who received
Wenfei Guyuan
Umbilical Moxibustion were recruited. The study data of 13 weeks of treatment and 26 weeks of follow-up were cleaned and sorted out. The patients were divided into an acute exacerbation group and a non-acute exacerbation group according to the presence or absence of acute exacerbation at the 13-week treatment stage and the 26-week follow-up stage, respectively. Lasso regression, elastic net, random forest and other methods were used to conduct preliminary screening of influencing factors. Then logistic regression analysis was performed on the common factors screened by any two methods to identify the factors affecting the effectiveness of
Wenfei Guyuan
Umbilical Moxibustion in treating stable COPD.
Results
2
A total of 107 patients were included. At the 13th weeks of treatment, five influencing factors were identified by any two of the methods including Lasso regression, elastic net and random forest, namely fatigue score, hemoglobin (HGB), Short Form 36-Item Health Survey (SF-36) physical function score, SF-36 social function score, and SF-36 physical pain score; logistic regression analysis showed that the factors affecting the effectiveness of
Wenfei Guyuan
Umbilical Moxibustion in treating COPD at 13 weeks were HGB (
OR=
0.973,
P=
0.031) and SF-36 social functioning score (
OR=
1.833,
P=
0.043). At 26 weeks of follow-up, seven influencing factors were identified by any two of the methods including Lasso regression, elastic net and random forest, namely expectoration score, wheezing score, fatigue score, SF-36 vitality score, SF-36 mental health score, the Modifi
ed Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease (mCOPD-PRO) environmental domain score, and the Modified of the Efficacy Satisfaction Questionnaire for patients with Chronic Obstructive Pulmonary Disease (mESQ-COPD) environmental adaptability score; logistic regression analysis showed that the factors affecting the effectiveness of
Wenfei Guyuan
Umbilical Moxibustion in treating COPD at 26 weeks were expectoration score (
OR=
2.175,
P=
0.042) and SF-36 mental health score (
OR=
1.312,
P=
0.012).
Conclusion
2
HGB, expectoration symptoms, social functioning, and mental health may be key factors affecting the clinical effectiveness of
Wenfei Guyuan
Umbilical Moxibustion in the treatment of COPD.
ADELOYE D , SONG P , ZHU Y , et al . Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a syste-matic review and modelling analysis [J]. Lancet Respir Med , 2022 , 10 ( 5 ): 447 - 458 .
WANG C , XU J , YANG L , et al . Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH]study):a national cross-sectional study [J]. Lancet , 2018 , 391 ( 10131 ): 1706 - 1717 .
易方莲 , 易松涛 . 慢性阻塞性肺疾病流行病学调查和防控措施研究 [J]. 解放军预防医学杂志 , 2018 , 36 ( 2 ): 171 - 173 .
FENS T , ZHOU G , POSTMA MJ , et al . Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed? [J]. Expert Opin Pharmacother , 2021 , 22 ( 7 ): 923 - 935 .
徐改萍 , 暴银素 , 董新刚 , 等 . 隔药脐灸疗法研究进展 [J]. 河南医学研究 , 2018 , 27 ( 3 ): 436 - 437 .
于子如 , 仙晋 , 王玲 , 等 . 脐灸对阈下抑郁患者肠道菌群的影响 [J]. 中国针灸 , 2024 , 44 ( 8 ): 881 - 888,918 .
陈永刚 . 温肺固元脐灸对慢阻肺急性加重、临床症状和生活质量影响的临床研究 [D]. 郑州 : 河南中医药大学 , 2022 .
XIAO Q , MENG Y , WANG G , et al . Effects of Wenfei Guyuan umbilical moxibustion on patients with stable chronic obstructive pulmonary disease: A multicenter randomized controlled trial [J]. Complement Ther Med , 2025 , 92 : 103194 . doi: 10.1016/j.ctim.2025.103194 http://dx.doi.org/10.1016/j.ctim.2025.103194 .
赖文浩 , 胡佳康 , 李德富 , 等 . 我国中老年人抑郁现状及影响因素的分析:基于LASSO-logistic模型 [J]. 现代预防医学 , 2025 , 52 ( 5 ): 875 - 879,892 .
张书迎 , 许珊 , 谭艳芳 , 等 . 基于LASSO回归与随机森林算法的心血管代谢性共病危险因素 [J]. 中华疾病控制杂志 , 2025 , 29 ( 1 ): 82 - 88 .
Global Initiative For Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 REPORT) [EB/OL]. ( 2019-11-05 )[ 2025-03-28 ]. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf .
中华医学会呼吸病学分会慢性阻塞性肺疾病学组 . 慢性阻塞性肺疾病诊治指南(2013年修订版) [J]. 中华结核和呼吸杂志 , 2013 , 36 ( 4 ): 255 - 264 .
中华中医药学会内科分会肺系病专业委员会 . 慢性阻塞性肺疾病中医证候诊断标准(2011版) [J]. 中医杂志 , 2012 , 53 ( 2 ): 177 - 178 .
Global Initiative For Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 REPORT) [EB/OL]. ( 2017-11-15 )[ 2025-03-30 ]. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf .
王明航 , 谢洋 , 李建生 , 等 . 慢性阻塞性肺疾病稳定期临床症状测评问卷信度、效度和反应度考核 [J]. 中医杂志 , 2015 , 56 ( 10 ): 831 - 835 .
张明月 , 田玉梅 , 高娥 , 等 . 慢性阻塞性肺疾病患者居家肺康复维持现状及影响因素研究 [J]. 中华护理杂志 , 2024 , 59 ( 17 ): 2077 - 2083 .
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test [J]. Am J Respir Crit Care Med , 2002 , 166 ( 1 ): 111 - 117 .
LI J , WANG J , XIE Y , et al . Development and validation of the modified patient-reported outcome scale for chronic obstructive pulmonary disease (mCOPD-PRO) [J]. Int J Chron Obstruct Pulmon Dis , 2020 , 15 : 661 - 669 . doi: 10.2147/COPD.S240842 http://dx.doi.org/10.2147/COPD.S240842 .
李建生 , 谢洋 , 王佳佳 , 等 . 慢性阻塞性肺疾病患者疗效满意度问卷修订版研制与评价 [J]. 中国全科医学 , 2022 , 25 ( 22 ): 2796 - 2803 .
张海彦 , 王强玉 , 谢安妮 , 等 . 针刺联合文拉法辛治疗产后抑郁障碍的疗效观察及对性激素水平、HAMD和SF-36评分的影响 [J]. 上海针灸杂志 , 2025 , 44 ( 1 ): 76 - 81 .
奚丽婧 , 郭昭艳 , 杨雪珂 , 等 . LASSO及其拓展方法在回归分析变量筛选中的应用 [J]. 中华预防医学杂志 , 2023 , 57 ( 1 ): 107 - 111 .
DAI P , CHANG W , XIN Z , et al . Retrospective study on the influencing factors and prediction of hospitalization expenses for chronic renal failure in China based on random forest and LASSO regression [J]. Front Public Health , 2021 , 9 : 678276 . doi: 10.3389/fpubh.2021. 678276 http://dx.doi.org/10.3389/fpubh.2021.678276 .
ZOU H , HASTIE T . Regularization and variable selection via the elastic net [J]. JRSSB , 2005 , 67 ( 2 ): 301 - 320 .
李华 , 刘佩林 , 董丹丹 , 等 . 血红蛋白、血清蛋白对老年左室功能正常不稳定型心绞痛PCI术病人预后的预测价值 [J]. 中西医结合心脑血管病杂志 , 2025 , 23 ( 3 ): 401 - 406 .
高理正 , 高鹏宇 . 血清PCT、IL-17及Hb水平在老年肺部感染患者中的诊断价值 [J]. 中国民康医学 , 2024 , 36 ( 4 ): 127 - 129,133 .
KOLLERT F , TIPPELT A , MÜLLER C , et al . Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure [J]. Respiratory Care , 2013 , 58 ( 7 ): 1204 - 1212 .
XU L , CHEN Y , XIE Z , et al . High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study [J]. BMC Pulm Med , 2019 , 19 ( 1 ): 174 .
王建青 . 血虚证与贫血的关系研究 [J]. 中国中医药信息杂志 , 1997 , 4 ( 12 ): 24 - 25 .
BURGEL PR , NESME-MEYER P , CHANEZ P , et al . Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects [J]. Chest , 2009 , 135 ( 4 ): 975 - 982 .
PELKONEN M , NOTKOLA IL , NISSINEN A , et al . Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men [J]. Chest , 2006 , 130 ( 4 ): 1129 - 1137 .
PRESCOTT E , LANGE P , VESTBO J . Chronic mucus hypersecretion in COPD and death from pulmonary infection [J]. Eur Respir J , 1995 , 8 ( 8 ): 1333 - 1338 .
彭鑫 , 刘健 , 栾哲宇 , 等 . 慢性阻塞性肺疾病气道黏液高分泌的发病机制及中医药干预的研究进展 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 4 ): 228 - 239 .
栾哲宇 , 王晗笑 , 彭鑫 , 等 . 基于“肺通调水道”理论探讨慢阻肺气道黏液高分泌的病机与治疗 [J/OL]. 辽宁中医杂志 .( 2024-12-16 )[ 2025-09-10 ]. https://link.cnki.net/urlid/21.1128.r.20241216.0920.076 https://link.cnki.net/urlid/21.1128.r.20241216.0920.076 .
BAKAS T , MCLENNON SM , CARPENTER JS , et al . Systematic review of health-related quality of life models [J]. Health Qual Life Outcomes , 2012 , 10 : 134 . doi: 10.1186/1477-7525-10-134 http://dx.doi.org/10.1186/1477-7525-10-134 .
MONTIEL AM , RUIZ-ESTEBAN P , DEL RÍO AD , et al . Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype [J]. Sci Rep , 2024 , 14 ( 1 ): 9687 .
XIE H , JIANG Y , LIU L , et al . Global prevalence and risk factors of depression in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis from 2000 to 2022 [J]. J Psychosom Res , 2023 , 175 : 111537 . doi: 10.1016/j.jpsychores.2023.111537 http://dx.doi.org/10.1016/j.jpsychores.2023.111537 .
ANDENAES R , KALFOSS MH . Psychological distress in hospitalized patients with chronic obstructive pulmonary disease [J]. Eur J Epidemiol , 2004 , 19 ( 9 ): 851 - 859 .
江宁 , 尹燕 , 侯刚 , 等 . 哮喘-慢阻肺重叠患者焦虑、抑郁状态调查分析 [J]. 中国医师杂志 , 2021 , 23 ( 7 ): 1007 - 1011 .
张淑利 , 张欣 , 刘银梅 . 社会、心理因素与稳定期慢阻肺患者急性加重的关系 [J]. 国际精神病学杂志 , 2024 , 51 ( 6 ): 1953 - 1956 .
刘摩 , 冯珍 . COPD合并焦虑症和抑郁症的研究进展 [J]. 临床合理用药 , 2023 , 16 ( 18 ): 175 - 178 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号